S-1
XBRL
REGISTRATION STATEMENT
- Company
- RELMADA THERAPEUTICS, INC.
- Filed
- August 12, 2019
- Accession Number
- 0001213900-19-015376
An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →